vimarsana.com

Latest Breaking News On - Medgenome inc - Page 1 : vimarsana.com

Non-Invasive Prenatal Testing (NIPT) Markets, 2033:

Liquid Biopsy Market is expected to grow at a CAGR of 20.9 % through the forecast period according to a new research report

Carrier Screening Global Market Report 2023: Increase in Fetal Chromosomal Abnormalities Drives Growth

/PRNewswire/ The "Carrier Screening Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. This report provides strategists,.

United-states
Cyprus
Switzerland
South-korea
Dublin
Ireland
Russia
Germany
India
France
Indonesia
Australia

Liquid Biopsy Global Market Report 2022: Growing

Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) The "Liquid Biopsy Market by Product (Assay Kits, Instruments), Circulating Biomarkers (CTC, ctDNA), Technology.

United-states
Dublin
Ireland
America
Asia-pacific
Anpac-bio
Science-co
Genome-diagnostics-inc
Medgenome-inc
Exosome-diagnostics-inc
Sysmex-inostics-subsidiary-of-corporation
Guardant-health-inc

Liquid Biopsy Market worth $10.0 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, Nov. 15, 2022 /PRNewswire/ Liquid Biopsy Market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% according to a new report by MarketsandMarkets.

United-states
Canada
United-kingdom
Switzerland
Northbrook
Illinois
Chicago
America
Kostenloser-wertpapierhandel
Asia-pacific
Aashish-mehra
Genome-diagnostics-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.